A Phase 2, Multicenter Study of FOLFIRINOX Followed by Ipilimumab in Combination With Allogeneic GM-CSF Transfected Pancreatic Tumor Vaccine (GVAX) in the Treatment of Metastatic Pancreatic Cancer
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2017
At a glance
- Drugs Ipilimumab (Primary) ; Tumour cell vaccine-GVAX (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin; Pegfilgrastim
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 21 Mar 2017 Planned End Date changed from 1 Nov 2018 to 1 Dec 2019.
- 21 Mar 2017 Status changed from recruiting to suspended.